Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Myalgic Encephalomyelitis: early-phase trial registry
3 of 6 indexed Myalgic Encephalomyelitis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Myalgic Encephalomyelitis: 6 US clinical trials tracked, 3 recruiting.
Myalgic Encephalomyelitis is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Icahn School of Medicine at Mount Sinai, running 2 of these trials.
Enrollment posture brief
Registry condition myalgic-encephalomyelitis
OPEN 3 | RECR 50% | LATE 0 | EARLY 3 | RANK #2866 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Achalasia (50% recruiting · 8 trials)
Myalgic Encephalomyelitis lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Myalgic Encephalomyelitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Myalgic Encephalomyelitis is recruiting above its size-band peers.
3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Myalgic Encephalomyelitis research.
Icahn School of Medicine at Mount Sinai accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Myalgic Encephalomyelitis enrolment sits around 106 participants.
Median target enrolment is 106 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.
-
Myalgic Encephalomyelitis research is mostly interventional.
6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
The Long COVID-19 Wearable Device Study
Scripps Translational Science Institute
NCT05741112
Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Icahn School of Medicine at Mount Sinai
NCT06511050
Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Weill Medical College of Cornell University
NCT04542161
Does a Technology Enabled Multi-disciplinary Team-based Care Model for the Management of Long COVID and Other Fatiguing Illnesses Improve Clinical Care of Patients and Represent a Sustainable Approach Within a Federally Qualified Health Center?
Family Health Centers of San Diego
NCT05167227
Cardiovascular Analysis of PEM
Icahn School of Medicine at Mount Sinai
NCT04740736
The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
Brigham and Women's Hospital
NCT03674541
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Myalgic Encephalomyelitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Myalgic Encephalomyelitis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Myalgic Encephalomyelitis page
6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Myalgic Encephalomyelitis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Icahn School of Medicine at Mount Sinai sponsors the most Myalgic Encephalomyelitis trials on record, review their full trial history before evaluating a specific study. See Icahn School of Medicine at Mount Sinai's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Myalgic Encephalomyelitis condition card totals 6 registered trials; most-linked intervention Saline Infusion; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.